Risk factors for Mycobacterium tuberculosis in US chronic dialysis patients
Open Access
- 12 September 2006
- journal article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 21 (11) , 3287-3292
Abstract
Background. End-stage renal disease is known to disrupt the cell-mediated immune response that is responsible for the killing of intracellular organisms such as Mycobacterium tuberculosis. Risk factors that contribute to the development of tuberculosis (TB) disease in the US dialysis population have not been studied on a large scale.Keywords
This publication has 10 references indexed in Scilit:
- Risk Factors for Tuberculosis Among Inmates: A Retrospective AnalysisPublic Health Nursing, 2005
- Mycobacterium Tuberculosis Infection Incidence in Hospitalized Renal Transplant Patients in the United States, 1998–2000American Journal of Transplantation, 2004
- Tuberculin skin testing underestimates a high prevalence of latent tuberculosis infection in hemodialysis patientsKidney International, 2004
- Pathways to a robust immune response in the elderlyImmunology and Allergy Clinics of North America, 2003
- Tuberculosis exposure of patients and staff in an outpatient hemodialysis unitAmerican Journal of Infection Control, 2002
- IMMUNOLOGIC DEFECTS AND VACCINATION IN PATIENTS WITH CHRONIC RENAL FAILUREInfectious Disease Clinics of North America, 2001
- Tuberculin and Anergy Skin Testing of Patients Receiving Long-term HemodialysisChest, 1998
- Immune Responses of Healthy Humans 83–104 Years of Age2JNCI: Journal of the National Cancer Institute, 1983
- Tuberculosis in patients undergoing maintenance hemodialysisThe American Journal of Medicine, 1979
- PROLONGED SURVIVAL OF SKIN HOMOGRAFTS IN UREMIC PATIENTSAnnals of the New York Academy of Sciences, 1957